Monday Feb 6 | BioSpace
DUSA Pharmaceuticals to Present at the 14th Annual Biotechnology...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia WILMINGTON, Mass., Feb.
Dusa Pharmaceuticals (DUSA) Downgraded by Zacks Investment Research
Dusa Pharmaceuticals was downgraded by Zacks Investment Research from an "outperform" rating to a "neutral" rating in a research note issued to investors on Saturday.
Leerink Analysts Initiate Coverage on Dusa Pharmaceuticals
Research analysts at Leerink initiated coverage on shares of Dusa Pharmaceuticals in a report issued on Wednesday.
Also on Topix